A newly released NACDS video urges this message ahead of a July 26 legislative markup scheduled by the U.S. Senate Committee on Finance.
The FTC on Thursday voted, 3-0, “to issue a statement cautioning against reliance on prior advocacy statements and studies related to pharmacy benefit managers (PBM) that no longer reflect current market realities.”
Through the engagement of the membership, NACDS brought its pro-patient and pro-pharmacy perspective to the IRA during its Congressional consideration and continues to shape the IRA during its implementation.
FTC: “The statement is a response to PBMs' continued reliance on older FTC advocacy materials”
“S. 1038 and S. 2052 are vital for real PBM reform, and for addressing ‘pharmaceutical benefit manipulation’ that harms the most vulnerable in the Medicaid and Medicare programs.”
NACDS is calling on North Carolina lawmakers to continue to stand up for North Carolinians in the face of “pharmaceutical benefit manipulation” in all its forms.
Utilize and share our “Unbreakable” TV/Digital Ad celebrating pharmacy’s dedication, Public Opinion Dashboard of attitudes on important topics, & Access Agenda’s pro-patient, pro-pharmacy policy priorities.
New PREP Act amendment issued today reflects strong and consistent urging of NACDS.
Article published in Johns Hopkins’ peer-reviewed Health Security journal follows a compelling announcement by the Biden Administration that gives states a window for action.
NACDS is thanking pharmacists and pharmacy teams for their help in ending the COVID-19 public health emergency.
